Lactulose (Lactulose) Patent Expiration, LOE Window & CMS Spending

Lactulose (Lactulose) by Solvay: Off-Patent Genericized (AB Competition), 12 AB generics, $73.6M 2024 CMS Part D & Medicaid spend, and 17 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSolvay
FDA Application & PathwayN017906 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors12
2024 CMS Total Public Spend$73.6M
2024 Medicare Part D Spend$60.5M
2024 Medicaid Spend$13.2M
Reported Wholesale Price Change (CA SB 17)17 WAC filings (max 167.3% 2-yr change)